Amylx Pharmaceuticals Inc vs Applied Digital Corporation — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Applied Digital Corporation trades at $32.12 (market cap $8.55B). The key difference: Applied Digital Corporation is far larger — about 3.2× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Applied Digital Corporation nearer its low. Which is the better fit depends on your goals.
| AMLX | APLD | |
|---|---|---|
Market Cap | $2.64B | $8.55B |
Sector | Health | Technology |
52-Week High | $24.19 | $49.65 |
52-Week Low | $7.82 | $13.89 |
Enterprise Value | $2.39B | $12.06B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Applied Digital (APLD) trades at $29.06, down 0.55% on the day, with a bearish technical signal and recent earnings misses. The company reported a net loss of $231.07 million in 2025 despite revenue growth, while analyst consensus remains strongly bullish with a $72.36 price target. Recent news highlights significant AI infrastructure contracts and insider selling activity.
Outlook hinges on execution of its $36 billion AI infrastructure pipeline, but risks include high cash burn, negative margins, and rising debt. The stock offers high growth potential if operational targets are met, yet financial sustainability concerns warrant caution for investors amid volatile sentiment.
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →Applied Digital provides high-performance computing (HPC) infrastructure and cloud services. It designs and operates data centers tailored for AI, machine learning, and other intensive digital workloads across North America.
Read more on APLD →